Unknown

Dataset Information

0

Miltefosine Combined with Intralesional Pentamidine for Leishmania braziliensis Cutaneous Leishmaniasis in Bolivia.


ABSTRACT: Bolivian cutaneous leishmaniasis due to Leishmania braziliensis was treated with the combination of miltefosine (150 mg/day for 28 days) plus intralesional pentamidine (120 ?g/mm2 lesion area on days 1, 3, and 5). Ninety-two per cent of 50 patients cured. Comparison to historic controls at our site suggests that the efficacy of the two drugs was additive. Adverse effects and cost were also additive. This combination may be attractive when a prime consideration is efficacy (e.g., in rescue therapy), avoidance of parenteral therapy, or the desire to treat locally and also provide systemic protection against parasite dissemination.

SUBMITTER: Soto J 

PROVIDER: S-EPMC6221230 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Miltefosine Combined with Intralesional Pentamidine for <i>Leishmania braziliensis</i> Cutaneous Leishmaniasis in Bolivia.

Soto Jaime J   Soto Paula P   Ajata Andrea A   Rivero Daniela D   Luque Carmelo C   Tintaya Carlos C   Berman Jonathan J  

The American journal of tropical medicine and hygiene 20181101 5


Bolivian cutaneous leishmaniasis due to <i>Leishmania braziliensis</i> was treated with the combination of miltefosine (150 mg/day for 28 days) plus intralesional pentamidine (120 μg/mm<sup>2</sup> lesion area on days 1, 3, and 5). Ninety-two per cent of 50 patients cured. Comparison to historic controls at our site suggests that the efficacy of the two drugs was additive. Adverse effects and cost were also additive. This combination may be attractive when a prime consideration is efficacy (e.g.  ...[more]

Similar Datasets

| S-EPMC4824229 | biostudies-literature
| S-EPMC8596449 | biostudies-literature
| S-EPMC3335687 | biostudies-literature
| S-EPMC4864077 | biostudies-literature
| S-EPMC3271977 | biostudies-literature